American College of Cardiology
As we all work together on the front lines to best serve our patients and lead COVID-19 response planning for our institutions, the ACC is working to provide COVID-19 clinical guidance for the global cardiovascular care team.
TCT 2022: PCSK9 Inhibition, FAVOR III China, and SCAAR Studies
Comments 0
Login to view comments.
Click here to Login
